HUE053977T2 - Szilárd gyógyszer színezõanyagok orális alkalmazására és diagnosztikai felhasználásra - Google Patents

Szilárd gyógyszer színezõanyagok orális alkalmazására és diagnosztikai felhasználásra

Info

Publication number
HUE053977T2
HUE053977T2 HUE15186682A HUE15186682A HUE053977T2 HU E053977 T2 HUE053977 T2 HU E053977T2 HU E15186682 A HUE15186682 A HU E15186682A HU E15186682 A HUE15186682 A HU E15186682A HU E053977 T2 HUE053977 T2 HU E053977T2
Authority
HU
Hungary
Prior art keywords
oral administration
solid drug
diagnostic use
diagnostic
drug
Prior art date
Application number
HUE15186682A
Other languages
English (en)
Hungarian (hu)
Inventor
Luigi Moro
Mauro Severino Ajani
Roberto Villa
Giuseppe Celasco
Alessandro Repici
Original Assignee
Cosmo Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Technologies Ltd filed Critical Cosmo Technologies Ltd
Publication of HUE053977T2 publication Critical patent/HUE053977T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/273—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes or gastroscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes or sigmoidoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/003—Thiazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0073—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form semi-solid, gel, hydrogel, ointment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/005—Devices for introducing or retaining media, e.g. remedies, in cavities of the body for contrast media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041—Capsule endoscopes for imaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HUE15186682A 2010-03-04 2011-03-02 Szilárd gyógyszer színezõanyagok orális alkalmazására és diagnosztikai felhasználásra HUE053977T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A000345A IT1398643B1 (it) 2010-03-04 2010-03-04 Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa
US32755710P 2010-04-23 2010-04-23

Publications (1)

Publication Number Publication Date
HUE053977T2 true HUE053977T2 (hu) 2021-07-28

Family

ID=42647312

Family Applications (3)

Application Number Title Priority Date Filing Date
HUE15186682A HUE053977T2 (hu) 2010-03-04 2011-03-02 Szilárd gyógyszer színezõanyagok orális alkalmazására és diagnosztikai felhasználásra
HUE11714409A HUE030246T2 (en) 2010-03-04 2011-03-02 Solid composition for the oral administration of dyes and diagnostic use thereof
HUS2100005C HUS2100005I1 (hu) 2010-03-04 2021-02-19 Metiltioninium-klorid

Family Applications After (2)

Application Number Title Priority Date Filing Date
HUE11714409A HUE030246T2 (en) 2010-03-04 2011-03-02 Solid composition for the oral administration of dyes and diagnostic use thereof
HUS2100005C HUS2100005I1 (hu) 2010-03-04 2021-02-19 Metiltioninium-klorid

Country Status (26)

Country Link
US (6) US8545811B2 (enExample)
EP (2) EP3011975B1 (enExample)
JP (1) JP5770752B2 (enExample)
KR (1) KR101763700B1 (enExample)
CN (1) CN102811747B (enExample)
AU (1) AU2011222496B2 (enExample)
BR (1) BR112012022373B1 (enExample)
CA (1) CA2790143C (enExample)
CY (1) CY1123967T1 (enExample)
DK (2) DK3011975T3 (enExample)
ES (2) ES2863986T3 (enExample)
FR (1) FR21C1009I1 (enExample)
HR (2) HRP20161366T1 (enExample)
HU (3) HUE053977T2 (enExample)
IL (1) IL221541A (enExample)
IT (1) IT1398643B1 (enExample)
LT (2) LT3011975T (enExample)
MX (1) MX342323B (enExample)
NZ (1) NZ602130A (enExample)
PL (2) PL3011975T3 (enExample)
PT (2) PT3011975T (enExample)
RS (2) RS55414B1 (enExample)
RU (1) RU2561034C2 (enExample)
SI (1) SI3011975T1 (enExample)
WO (1) WO2011107945A1 (enExample)
ZA (1) ZA201206360B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000076478A1 (en) 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US9072583B2 (en) 2008-10-16 2015-07-07 Obalon Therapeutics, Inc. Intragastric volume-occupying device and method for fabricating same
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
EP2722058A1 (en) * 2012-10-19 2014-04-23 Cosmo Technologies Ltd Solid oral composition containing dyes for use in endoscopic diagnosis
MX382932B (es) * 2014-01-29 2025-03-13 Cosmo Tech Limited Composición líquida en forma de emulsión o microemulsión para administración rectal que contiene al menos un tinte, y su uso en un procedimiento endoscópico de diagnóstico de colon sigmoide y/o recto.
US10124074B2 (en) * 2014-02-26 2018-11-13 Toufic Kachaamy Indirect chromoendoscopy with an oral indigo carmine base preparation
EP3229849B1 (en) 2014-12-08 2024-12-25 Kinnos Inc. Additive compositions for pigmented disinfection and methods thereof
US20180116849A1 (en) * 2015-04-23 2018-05-03 Obalon Therapeutics, Inc. Systems and methods for determining failure of intragastric devices
WO2017139670A1 (en) * 2016-02-12 2017-08-17 Kinnos Inc. Compositions and methods for use in surface decontamination
AU2017253527A1 (en) 2016-04-19 2018-11-01 Christian-Albrechts-Universität Zu Kiel Shellac microcapsule formulations and compositions
CA3031522A1 (en) 2016-07-25 2018-02-01 Kinnos Inc. Device and related compositions and methods for use in surface decontamination
RU2019118459A (ru) 2016-11-28 2020-12-28 Космо Текнолоджиз Лтд. Твердая пероральная композиция, содержащая красители
FR3059664B1 (fr) 2016-12-01 2019-01-25 Provepharm Life Solutions Procede de preparation du carmin d’indigo
US11464371B2 (en) 2018-07-12 2022-10-11 Kinnos Inc. Devices, compositions, and methods for use in surface decontamination
CN108888765B (zh) * 2018-07-16 2021-02-26 山东理工大学 一种释放亚甲基蓝聚集体的含亚甲基蓝的二氧化硅/虫胶复合颗粒的制备方法
CN111184876B (zh) * 2020-02-20 2022-03-04 沈伟 一种消化道黏膜染色剂、制备方法及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
CA2097695C (en) * 1991-10-31 2000-08-08 Mark J. Malmros Biological stain composition, method of preparation and method of use for delineation of epithelial cancer
US6405070B1 (en) * 1998-06-16 2002-06-11 Bhaskar Banerjee Detection of cancer using cellular autofluorescence
WO2000076478A1 (en) 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
US6584630B1 (en) 2000-04-06 2003-07-01 Ohio Medical Instrument Company, Inc. Radiolucent surgical table extension assembly and method
WO2001076478A1 (en) 2000-04-10 2001-10-18 Nordisk Terapi As System for testing and exercising sensorimotoric control of the neck
FR2829933B3 (fr) * 2001-09-21 2004-03-12 Ellipse Pharmaceuticals Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
US7217410B2 (en) 2003-06-17 2007-05-15 The Board Of Trustees Of The Universtiy Of Illinois Surface modified protein microparticles
US20070116757A1 (en) * 2005-11-08 2007-05-24 Collegium Pharmaceutical, Inc. Methylene Blue Derivatives
FR2894253B1 (fr) * 2005-12-06 2009-11-13 Pentax Corp Composition d'histocolorant pour endoscope

Also Published As

Publication number Publication date
JP2013521271A (ja) 2013-06-10
US20200268909A1 (en) 2020-08-27
HUS2100005I1 (hu) 2021-03-29
AU2011222496B2 (en) 2016-08-18
RU2012142192A (ru) 2014-04-10
LT2542268T (lt) 2016-12-12
FR21C1009I1 (fr) 2021-05-07
RS55414B1 (sr) 2017-04-28
PT2542268T (pt) 2016-11-14
DK2542268T3 (en) 2016-11-28
MX2012010125A (es) 2013-02-26
HUE030246T2 (en) 2017-04-28
CA2790143A1 (en) 2011-09-09
US20130295013A1 (en) 2013-11-07
US10265420B2 (en) 2019-04-23
ES2863986T3 (es) 2021-10-13
LT3011975T (lt) 2021-04-26
PT3011975T (pt) 2021-03-19
JP5770752B2 (ja) 2015-08-26
US20130287690A1 (en) 2013-10-31
EP3011975A1 (en) 2016-04-27
DK3011975T3 (da) 2021-03-29
EP2542268B1 (en) 2016-08-10
IL221541A (en) 2016-03-31
MX342323B (es) 2016-09-23
PL2542268T3 (pl) 2017-05-31
ZA201206360B (en) 2013-10-30
KR20130015008A (ko) 2013-02-12
IT1398643B1 (it) 2013-03-08
ITMI20100345A1 (it) 2011-09-05
AU2011222496A2 (en) 2012-09-20
AU2011222496A1 (en) 2012-09-20
US9402922B2 (en) 2016-08-02
CA2790143C (en) 2019-01-22
US20180214580A1 (en) 2018-08-02
KR101763700B1 (ko) 2017-08-01
WO2011107945A1 (en) 2011-09-09
US8545811B2 (en) 2013-10-01
BR112012022373B1 (pt) 2021-12-14
RS61641B1 (sr) 2021-04-29
CN102811747B (zh) 2016-02-24
CN102811747A (zh) 2012-12-05
SI3011975T1 (sl) 2021-05-31
EP3011975B1 (en) 2021-01-20
CY1123967T1 (el) 2022-05-27
BR112012022373A2 (pt) 2019-11-26
EP2542268A1 (en) 2013-01-09
RU2561034C2 (ru) 2015-08-20
US20160184460A1 (en) 2016-06-30
US20130058867A1 (en) 2013-03-07
HRP20210493T1 (hr) 2021-05-14
US9402923B2 (en) 2016-08-02
HRP20161366T1 (hr) 2017-02-24
ES2602157T3 (es) 2017-02-17
NZ602130A (en) 2014-07-25
PL3011975T3 (pl) 2021-06-28

Similar Documents

Publication Publication Date Title
HUS2100018I1 (hu) Hatóanyagok légúti beadására alkalmas készítmények és ezekkel kapcsolatos eljárások
HUS2100032I1 (hu) Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk
HUE053357T2 (hu) Gyógyszerészeti készítmény és annak beadásai
HUS1900017I1 (hu) Gyûrûs boronsavészter-származékok és terápiás alkalmazásuk
PL2464342T3 (pl) Formulacje farmaceutyczne do zapobiegania niewłaściwemu użyciu leków medycznych
SMT201500232B (it) Dispositivo per la somministrazione de farmaci
IL221541A (en) Solid composition for the oral administration of dyes and diagnostic use thereof
IL223455B (en) Oral modified release pharmaceutical composition comprising immediate and delayed release febuxostat beads and use thereof
EP2132133A4 (en) RELEASE OF PARTICULATE ACTIVE SUBSTANCES
HUE046748T2 (hu) Orális beadásra szánt kortikoszteroid készítmények
LT2493474T (lt) Būdai ir kompozicijos prolonguotam vaistų įvedimui
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
HUE042105T2 (hu) Oxikodont és naloxont tartalmazó azonnali hatóanyagleadású orális gyógyászati készítmények
IL216668A (en) Pharmaceutical composition and use thereof for preparation of a medicament for emergency contraception
DK2652652T3 (da) Medikmentadministration
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
FI2575785T3 (fi) Bendamustiinin oraalisia annostelumuotoja ja niiden terapeuttinen käyttö
FR2959935B1 (fr) Forme pharmaceutique orale alcoolo-resistante
FI20115738L (fi) Apuväline suun ja hampaiden hoidon yhteydessä
ZA201509239B (en) Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration
EP2647381A4 (en) MELTING TABLET
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
BRPI1007484A2 (pt) composição farmacêutica para administração oral
BRPI0918539A2 (pt) preparação farmacêutica sólida para administração oral
SMT201500005B (it) Composizione framaceutica inalabile